Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor

doi:10.3748/wjg.15.5867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4274)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

416

HTML

3628

Figures (1-3)

230

Sum=4274

Dec 14, 2009 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (69)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Dec 14, 2009; 15(46): 5867-5870
Published online Dec 14, 2009. doi: 10.3748/wjg.15.5867

Full Size Figure Download Figure

Figure 2 Gallium-68 DOTA-NOC PET-CT in the follow up. A: Octreotide scan prior to PRRT-1, Gallium-68 DOTA NOC PET-CT and prior operation, showing multiple paraaortal lymph nodes next to the pancreas head; B: 3 mo after PRRT-1; C: 5 mo after PRRT-2 showing consistently decreasing mesenterial lymph nodes metastases with a decreasing SUV; D: Octreotide scan as follow up 18 mo after operation-complete remission.

Citation: Kaemmerer D, Prasad V, Daffner W, Hörsch D, Klöppel G, Hommann M, Baum RP. Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor. World J Gastroenterol 2009; 15(46): 5867-5870
URL: https://www.wjgnet.com/1007-9327/full/v15/i46/5867.htm
DOI: https://dx.doi.org/10.3748/wjg.15.5867